Preisträger stellen sich vor: Tobias Welponer und Johanna Strobl erhalten den LEO Pharma Young Researcher Award der ÖGDV 2023
2024; Wiley; Volume: 22; Issue: 5 Linguagem: Alemão
10.1111/ddg.15447_g
ISSN1610-0387
AutoresTobias Welponer, Johanna Strobl,
Tópico(s)Dermatology and Skin Diseases
ResumoJDDG: Journal der Deutschen Dermatologischen GesellschaftVolume 22, Issue 5 p. 755-756 FORUM – ÖGDV Preisträger stellen sich vor: Tobias Welponer und Johanna Strobl erhalten den LEO Pharma Young Researcher Award der ÖGDV 2023 Tobias Welponer, Tobias WelponerSearch for more papers by this authorJohanna Strobl, Corresponding Author Johanna Strobl [email protected] Korrespondenzanschrift Dr. Johanna Strobl, PhD, Medizinische Universität Wien, Universitätsklinik für Dermatologie, Währinger Gürtel 18–20, 1090 Wien, Österreich. Email: [email protected]Search for more papers by this author Tobias Welponer, Tobias WelponerSearch for more papers by this authorJohanna Strobl, Corresponding Author Johanna Strobl [email protected] Korrespondenzanschrift Dr. Johanna Strobl, PhD, Medizinische Universität Wien, Universitätsklinik für Dermatologie, Währinger Gürtel 18–20, 1090 Wien, Österreich. Email: [email protected]Search for more papers by this author First published: 10 May 2024 https://doi.org/10.1111/ddg.15447_gRead the full textAboutPDF ToolsRequest permissionExport citationAdd to favoritesTrack citation ShareShare Give accessShare full text accessShare full-text accessPlease review our Terms and Conditions of Use and check box below to share full-text version of article.I have read and accept the Wiley Online Library Terms and Conditions of UseShareable LinkUse the link below to share a full-text version of this article with your friends and colleagues. Learn more.Copy URL Share a linkShare onEmailFacebookTwitterLinkedInRedditWechat No abstract is available for this article. LITERATUR 1Strobl J, Pandey RV, Krausgruber T, et al. Long-term skin-resident memory T cells proliferate in situ and are involved in human graft-versus-host disease. Sci Transl Med. 2020; 12(570):eabb7028. 10.1126/scitranslmed.abb7028 CASPubMedWeb of Science®Google Scholar 2Strobl J, Gail LM, Krecu L, et al. Diverse macrophage populations contribute to distinct manifestations of human cutaneous graft-versus-host disease. Br J Dermatol. 2024; 190(3): 402-414. 10.1093/bjd/ljad402 PubMedGoogle Scholar 3Döbel T, Schäkel K. Transcriptional landscape of macrophages in cutaneous graft-versus-host disease. Br J Dermatol. 2024; 190(3): 298 10.1093/bjd/ljad458 PubMedGoogle Scholar 4Fine JD, Johnson LB, Weiner M, et al. Epidermolysis bullosa and the risk of life-threatening cancers: the National EB Registry experience, 1986–2006. J Am Acad Dermatol. 2009; 60(2):203-11. 10.1016/j.jaad.2008.09.035 PubMedWeb of Science®Google Scholar 5Welponer T, Weber DD, Trattner L, et al. Metformin shows anti-neoplastic properties by inhibition of oxidative phosphorylation and glycolysis in epidermolysis bullosa-associated aggressive cutaneous squamous cell carcinoma. J Eur Acad Dermatol Venereol. 2024; 38(1): 112-123. 10.1111/jdv.19488 CASPubMedGoogle Scholar 6Coyle C, Cafferty FH, Vale C, Langley RE. Metformin as an adjuvant treatment for cancer: a systematic review and meta-analysis. Ann Oncol. 2016; 27(12): 2184-2195. 10.1093/annonc/mdw410 CASPubMedWeb of Science®Google Scholar Volume22, Issue5May 2024Pages 755-756 ReferencesRelatedInformation
Referência(s)